Comparison of the Efficacy and Safety of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Insufficiently Controlled With Non-insulin Antidiabetic Therapy
Clinical trial NCT02855684 · COMPLETED
Trial details
- NCT number
- NCT02855684
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-24
- Primary completion
- 2018-08-06
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.